Sterile injectable CDMO with rapid facility expansion underway
August Bioservices operates a contract development and manufacturing organization (CDMO) focused on sterile injectables—vials, syringes, flexible IV bags—for pharma and biotech clients. The company is mid-expansion: active projects span new facility construction, manufacturing qualification, and warehouse system implementation, while pain points cluster around scaling capacity, GMP compliance, and technology transfer. Hiring velocity is decelerating despite 41 open roles, suggesting capital or operational constraints around the build-out.
August Bioservices is a sterile injectable CDMO headquartered in Nashville, Tennessee, founded in 2020. The company offers end-to-end services spanning formulation development, aseptic and terminal sterilization filling, microbiology, analytical chemistry, process development, stability programs, and commercial manufacturing. Client base includes pharma and biotech firms across preclinical through commercial production phases. Recent renovations and two major facility expansions position the organization to increase manufacturing capacity and support new product introductions.
August provides sterile injectable CDMO services including aseptic filling, terminal sterilization, formulation development, microbiology, analytical chemistry, process development, and stability testing for vials, syringes, and flexible IV bags.
August Bioservices is headquartered in Nashville, Tennessee. The company operates 51–200 employees and is currently executing facility expansion and construction projects.
Other companies in the same industry, closest in size